Page last updated: 2024-08-21

quinazolines and Incontinentia Pigmenti Achromians

quinazolines has been researched along with Incontinentia Pigmenti Achromians in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cáncela-Díez, B; Cuenca-Barrales, C; Galvez-Moreno, M; López-Delgado, D; Ruiz-Villaverde, R1
Robert, C; Sibaud, V1
Ishikawa, T; Kamide, R; Niimura, M1

Reviews

1 review(s) available for quinazolines and Incontinentia Pigmenti Achromians

ArticleYear
[Pigmentary disorders induced by anticancer agents. Part II: targeted therapies].
    Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Cetuximab; Dasatinib; ErbB Receptors; Humans; Imatinib Mesylate; Indazoles; Indoles; Ipilimumab; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Piperazines; Piperidines; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Sunitinib; Thiazoles

2013

Other Studies

2 other study(ies) available for quinazolines and Incontinentia Pigmenti Achromians

ArticleYear
Gray-bluish cutaneous pigmentation and ice-pick scars induced by vandetanib therapy.
    International journal of dermatology, 2018, Volume: 57, Issue:7

    Topics: Adult; Antineoplastic Agents; Cicatrix; Color; Drug Eruptions; Facial Dermatoses; Female; Humans; Pigmentation Disorders; Piperidines; Quinazolines

2018
Photoleukomelanodermatitis (Kobori) induced by afloqualone.
    The Journal of dermatology, 1994, Volume: 21, Issue:6

    Topics: Aged; Drug Eruptions; Humans; Male; Muscle Relaxants, Central; Photosensitivity Disorders; Pigmentation Disorders; Quinazolines

1994